Custom Synthesis of (1S,2S)-trans-N-Boc-1,2-cyclopentanediamine

The contract involves the custom synthesis and delivery of 200 grams of (1S,2S)-trans-N-Boc-1,2-cyclopentanediamine, a specialized chiral diamine precursor essential for research focused on developing peptide nucleic acids targeting HIV and cancer. This work supports the National Institutes of Health under the Department of Health and Human Services. The contract is classified as a subcontract within the chemical manufacturing industry (NAICS code 325199) and is intended to be performed in Llanera, with a delivery deadline shortly after the solicitation period. The solicitation was posted on June 10, 2026, with responses due by June 19, 2026. While specific details about the contractor or point of contact are not provided, the contract highlights a focused effort to provide high-quality, custom synthesis services to aid important biomedical research initiatives. The material’s role as a precursor underscores the contract’s critical contribution to advancing therapeutic development in infectious disease and oncology areas.